JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Latest Updates

This page lists all changes to CB-DSG 203 after Release 02.
This page constitutes Section 2 of Appendix 1 - Changes to donor selection guidelines.

Changes Introduced with Release 53

Eye Disease - Change Notification No. 35 - 2023

Changes Introduced with Release 52

Coronavirus Infection (COVID-19) - Change Notification No. 33 - 2023

Changes Introduced with Release 51

Changes arising from the FAIR III report - Change Notification No. 17 - 2023

Changes Introduced with Release 50

Tuberculosis - Change Notification No. 25 - 2023
Tissue and Cell Allograft Recipients - Change Notification No. 14 - 2023

Changes Introduced with Release 49

Mpox (Monkeypox) - Change Notification No. 13 - 2023

Changes Introduced with Release 48

Coronavirus Infection (COVID-19) - Change Notification No. 51 - 2022
Infectious Diseases, Contact with - Change Notification No. 52 - 2022

Changes Introduced with Release 47

Table of Immunisations - Change Notification No. 55 - 2022

Changes Introduced with Release 46

Animal Bite - Change Notification No. 35 - 2022
Malaria - Change Notification No. 37 - 2022
Monkeypox - Change Notification No. 41 - 2022

Changes Introduced with Release 45

Tropical Viruses - Change Notification No. 21 - 2022

Changes Introduced with Release 44

Coronavirus Infection- Change Notification No. 30 - 2022

Changes Introduced with Release 43

Infertility- Change Notification No. 13 - 2022
Psoriasis - Change Notification No. 14 - 2022
Body Piercing - Change Notification No. 15 - 2022
Cervical Dysplasia - Change Notification No. 16 - 2022
Diseases of unknown aetiology - Change Notification No. 17 - 2022

Changes Introduced with Release 42

Complementary Therapy - Change Notification No. 04 - 2022

Changes Introduced with Release 41

Acne & Teratogenic Medication - Change Notification No.19 - 2021
Colitis, Proctitis & Gastrointestinal Disease - Change Notification No. 20 - 2021
Coronavirus Infection - Change Notification No. 22 - 2021
Immunization - Change Notification No. 26 - 2021
Infertility - Change Notification No. 27 - 2021
Surgery - Change Notification No. 29 - 2021
Thrush Oral & Vaginal - Change Notification No. 30 - 2021
Toxoplasmosis - Change Notification No. 31 - 2021

Changes Introduced with Release 40

COVID-19 Vaccination - Change Notification No.05 - 2021

Changes Introduced with Release 39

COVID-19 Vaccine - Change Notification No.74 - 2020

Changes Introduced with Release 38

Tamoxifen - Change Notification No. 42 - 2020
Infection - Chronic - Change Notification No. 43 - 2020
South American Trypanosomiasis Risk - Change Notification No. 44 - 2020
Transfusion - Change Notification No. 45 - 2020
Sexually Transmitted Disease - Change Notification No. 61 - 2020

Changes Introduced with Release 37

Animal Bite - Change Notification No. 36 - 2020
Rabies - Change Notification No. 37 - 2020
Viral Haemorragic Fever - Change Notification No. 38 - 2020
Tamiflu & Relenza - Change Notification No. 40 - 2020
Infection - Acute - Change Notification No. 41 - 2020

Changes Introduced with Release 36

Coronavirus Infection - Change Notification No. 31 - 2020

Changes Introduced with Release 35

Coronavirus Infection - Change Notification No. 17 - 2020

Changes Introduced with Release 34

Coronavirus Infection - Change Notification No. 10 - 2020

Changes Introduced with Release 33

Coronavirus Infection - Change Notification No. 08 - 2020

Changes Introduced with Release 32

Coronavirus Infection - Change Notification No. 05-2020

Changes Introduced with Release 31

Hepatitis A - Change Notification No. 12-2019
Pre & Post Exposure for HIV - Change Notification No. 13-2019
Tissue Safety Entry - Change Notification No. 14-2019
Viral Haemorrhagic Fever - Change Notification No. 15-2019
Complementary Therapy - Change Notification No. 17 - 2019
Hepatitis C - Change Notification No. 19 - 2019
Infammatory Bowel - Change Notification No. 20 - 2019
Malignancy - Change Notification No. 22 - 2019
Sexually Transmitted Diseases - Change Notification No. 23 - 2019

Changes Introduced with Release 30

Infection - Acute - Change Notification 26-2018
Infection - Chronic - Change Notification 28-2018

Changes Introduced with Release 29

Central Nervous System Disease - Change Notification No. 04 - 2018
G6PD Deficiency - Change Notification No. 05 - 2018
Glycogen Storage Disease - Change Notification No. 06 - 2018
Haemoglobin Disorders - Change Notification No. 08 - 2018
Hepatitis A - Change Notification No. 09 - 2018
Hepatitis E - Change Notification No. 10 - 2018
Pregnancy - Change Notification No. 11 - 2018
Transfusion - Change Notification No. 14 - 2018
Viral Haemorrhagic Fever - Change Notification No. 15 - 2018

Changes Introduced with Release 28

Poisoning - Change Notification 01-2018

Changes Introduced with Release 27

Radiation Therapy - Change Notification No.22 - 2017
Tissue and Organ Recipients - Change Notification No.23 - 2017
Surgery - Change Notifcation No.24 - 2017
Tissue Safety Entry - Change Notification No. 27 - 2017
Addiction and Drug Abuse - Change Notification No. 28 - 2017
Body Piercing - Change Notification No. 30 - 2017
Complementary Therapy - Change Notification No. 32 - 2017
Hepatitis B - Change Notification No. 34 - 2017
Hepatitis C - Change Notification No. 36 - 2017
HIV - Change Notification No. 38 - 2017
HTLV - Change Notification No. 42 - 2017
Inoculation Injury - Change Notification No. 43 - 2017
Sex Worker - Change Notification No. 46 - 2017
Syphilis - Change Notification No. 48 - 2017
Bleeding Disorder - Change Notification No. 50 - 2017

Changes Introduced with Release 26

Malaria - Change Notification No.17 - 2017

Changes Introduced with Release 25

Kidney Stones - Change Notification No.07 - 2017

Changes Introduced with Release 24

Hepatitis A - Change Notification No.46 - 2016

Changes Introduced with Release 23

Endoscopy - - Change Notificaiton No. 24 - 2016
Severe Exercise Intolerance Disease (SEID) - Change Notification No. 28 - 2016
Xenotransplantation - Change Notification No. 29 - 2016

Changes Introduced with Release 22

Tropical Viruses - Change Notification No. 013 - 2016
Viral Haemorrhagic Fever - Change Notification No. 015 - 2016

Changes Introduced with Release 21

Appendix 2 Table of Immunizations - Change Notification No. 04 - 2016
Tropical Viruses - Change Notification No. 07 - 2016
West Nile Virus - Change Notification No. 09 - 2016
Viral Haemorrhagic Fever - Change Notification No. 11 -2016

Changes Introduced with Release 20

Complementary Therapy - Change Notification No. 12 - 2015
Injectable Tanning Agents - Change Notification No.15 - 2015

Changes Introduced with Release 19

Communication Difficulties - Change Notification No.7 - 2015
Complementary Therapy - Change Noficiation No.8 - 2015
Infertility - Change Notification No.9 - 2015

Changes introducted with Release 18

Viral Haemorrhagic Fever Risk - Change Notification No. 43 – 2014

Changes intorduced with Release 17

Haematological Disease - Change Notification No. 30 - 2014
SARS - Change Notification No.31 - 2014
Tissue Safety - Change Notification No.32 - 2014
Steroid Therapy - Change Notificiation No.33 - 2014
Homosexual and Bisexual Individuals - Change Notifcation No.35 - 2014

Changes introduced with Release 16

Acupuncture - Change Notification No. 02 - 2014
Alitretinoin, Toctino, Acne and Dermatitis - Change Notification No. 03 - 2014
Body Piercing - Change Notification No. 04 - 2014
Central Nervous System Disease - Change Notification No. 05 - 2014
Hepatitis B - Post Immunization - Change Notification No. 06 - 2014
Hepatitis B - Change Notification No. 07 - 2014
Hepatitis of Unknown Origin - Change Notification No. 08 - 2014
Infection - Acute - Change Notification No. 09 - 2014
Kidney Disease - Change Notification No. 10 - 2014
Malignancy - Change Notification No. 11 - 2014
Mental Health Problems - Change Notification No. 12 - 2014
Sarcoidosis - Change Notification No. 13 - 2014
South American Trypanosomiasis Risk - Change Notification No. 14 - 2014
Paratyphoid and Typhoid - Change Notification No. 15 - 2014

Changes introduced with Release 15

Hepatitis B - Change Notification No. 08 - 2013
Hepatitis B Post Immunization - Change Notification No. 09 - 2013
Infection - Chronic - Change Notification No. 10 - 2013

Changes introduced with Release 14

West Nile Virus (WNV) - Change Notification No. 01 - 2013

Changes introduced with Release 13 Issue 02

Fertility treatment: entry replaced by link to infertility

Changes introduced with Release 13

Acne - Change Notification No. 15 - 2012
Psoriasis - Change Notification No. 17 - 2012
Toxoplasmosis - Change Notification No. 18 - 2012

Changes introduced with Release 12

West Nile Virus (WNV) Change Notification No. 05 - 2012

Changes introduced with Release 11

XMRV - Change Notification No. 25 - 2011
Hepatitis C - Change Notification No. 27 - 2011

Changes introduced with Release 10

Porphyria - Change Notification No. 20 - 2011

Changes introduced with Release 09

West Nile Virus - Change Notification No. 11 - 2011

Changes introduced with Release 08

Infertility - Change Notification No. 08 - 2011
Sexually Transmitted Disease - Change Notification No. 09 - 2011

Changes introduced with Release 07

West Nile Virus (WNV) - Change Notification No. 09 - 2010

Changes introduced with Release 06

Body Piercing - Change Notification No. 02 - 2010
Endoscopy - Change Notification No. 03 - 2010
Inoculation Injury - Change Notification No. 04 - 2010

Changes introduced with Release 05

Acupuncture - Change Notification No. 33 - 2009
Complementary Therapy - Change Notification No. 35 - 2009

Changes introduced with Release 04

Tamiflu® (oseltamivir) - Change Notification No. 30 - 2009
Relenza® (zanamivir) - Change Notification No. 31 - 2009

Changes introduced with Release 03

Bleeding Disorder - Change Notification No. 18 - 2007

A change was made to the version control definitions and all Issue numbering information removed.

Last updated 29/01/2024